BYOMass Company
BYOMass is developing therapeutics to modulate the central control of metabolism associated with aging and age-related chronic illnesses.
Founded Date:
2017
Total Funding:
1500000
Investor Type:
Company
Employee Number:
1-10
Number Of Exists:
Venture - Series Unknown
Technology:
Geroscience
Last Funding Type:
Venture - Series Unknown
Investors Number:
1
Last Funding Date:
2019
Industry:
Biotechnology
Headquarters:
Sudbury, Massachusetts, United States